
Image via PRN — Energy & Environment
Last updated
Medtronic: Ma Activity
Medtronic completed its acquisition of Scientia Vascular, integrating neurovascular access and therapeutic portfolios.
Source: PRN — Energy & Environment
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
Market context: This lands while the Talent Market Index reads 112.8 (Hot) — up 11.4 versus the prior month — and EMEA signal share is easing (-3.2pts).
Medtronic: 4 signals in the last 90 days — above the MedTech median of 1 across 19 tracked companies; 0.2% of MitchelLake's EMEA signal flow; 4 tracked across 31 days.
Also at Medtronic →
More signals across MedTech
Product Launch · EMEA
Abbott →Abbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Partnership · EMEA
Cepheid →Cepheid launched landmark 30-month study with the Fleming Initiative at London NHS Trusts to evaluate rapid CPE screening for drug-resistant infections
Product Launch · EMEA
ZEISS Medical Technology →ZEISS successfully completed early clinical implantations of AT LUCIA toric 721P intraocular lens across six European countries. Product is CE marked and expected to launch commercially in select European markets later in 2026.
Product Launch · EMEA
Sonova →Sonova aims for cochlear implant market comeback with new technology after experiencing sales slump
Partnership · EMEA
Sectra →Sectra signed contract to deliver enterprise imaging cloud service to six NHS Trusts in London
Strategic Hiring · EMEA
Renishaw →Renishaw upgraded profit guidance due to strong demand from defense contractors and chipmakers for their precision lithography equipment
Intelligence powered by Autonodal ↗
